Delaying the second dose of Novavax’s Covid vaccine by up to 12 weeks should be ‘fine’

Professor Paul Heath said a 12-week dosing gap would most likely not make the Novavax jab less effective Novavax’s Covid vaccine will ‘probably’ still be effective if the second dose is delayed by up to 12 weeks, according to one of the firm’s top scientists.  Professor Paul Heath argued that ‘basic immunological principles’ suggested the … Read more

UK signs deal with GlaxoSmithKline to ‘fill and finish’ 60million doses of Novavax’s Covid vaccine

Boris Johnson tonight revealed GlaxoSmithKline will support the manufacturing of up to 60million doses of the Novavax coronavirus vaccine in the UK. No10’s vaccines taskforce has signed a deal with British drugs giant GSK to ‘fill and finish’ supplies of the American jab at its factory in Durham starting from May. Mr Johnson said the move … Read more

UK signs deal with GlaxoSmithKline to ‘fill and finish’ 60million doses of Novavax’s Covid vaccine

The Government has agreed a deal with pharmaceutical giant GlaxoSmithKline (GSK) on the manufacture of up to 60 million doses of the Novavax coronavirus vaccine. Here is what we know: – How does the vaccine work? The Novavax vaccine works like other vaccines by teaching the immune system to make antibodies to the coronavirus spike … Read more

Novavax’s COVID-19 vaccine prevents 96% of infections against original strain of the virus

Novavax Inc’s experimental COVID-19 vaccine is safe and 96 percent effective at preventing infection, but possibly not against all variants, trial data shows. On Thursday, the Gaithersburg, Maryland-based company released results from two clinical trials, one held in the UK and the other in South Africa.  Both countries have seen highly infectious variants crop up … Read more

Novavax’s COVID-19 vaccine prevents 96% of infections against original strain of the virus

BREAKING NEWS: Novavax’s COVID-19 vaccine prevents 96% of infections against original strain of the virus including 86.3% of UK ‘super-covid’ cases – but is only 55.4% effective against the South Africa variant Novavax’s vaccine uses synthesized pieces of the surface protein that the coronavirus uses to invade human cells and spurs antibody production In a … Read more

Novavax’s COVID-19 vaccine prevents 90% of infections

BREAKING NEWS: Novavax’s COVID-19 vaccine prevents 90% of infections including 85% of UK ‘super-covid’ cases – but it is only 50% effective against the South Africa variant Novavax’s vaccine uses synthesized pieces of the surface protein that the coronavirus uses to invade human cells and spurs antibody production  In a late-stage UK study, the vaccine … Read more

Novavax’s COVID-19 vaccine prevents 90% of infections

BREAKING NEWS: Novavax’s COVID-19 vaccine prevents 90% of infections including 85% of UK ‘super-covid’ cases – but it is only 50% effective against the South Africa variant Novavax’s vaccine uses synthesized pieces of the surface protein that the coronavirus uses to invade human cells and spurs antibody production  In a late-stage UK study, the vaccine … Read more

Novavax’s experimental coronavirus vaccine triggered antibodies in 100% of trial participants

Novavax’s experimental coronavirus vaccine triggered antibodies in 100% of trial participants, study reveals Novavax published ‘positive data’ from a phase 1 trial of its coronavirus vaccine in the New England Journal of Medicine on Friday  All 108 volunteers dosed with the vaccine developed a antibodies to coronavirus after their second shot  Novavax is launching its … Read more